Literature DB >> 21509207

Asthma Control in Oman: National Results within the Asthma Insights and Reality in the Gulf and the Near East (AIRGNE) Study.

Nasser Al-Busaidi1, Joan B Soriano.   

Abstract

OBJECTIVES: The Asthma Insights and Reality (AIR) study in the Gulf and Near East (one of a worldwide series of surveys conducted in adults and children to assess asthma control) was conducted in Oman to assess how closely asthma control meets international guidelines recommendations.
METHODS: From January 2007 to March 2008, asthmatics receiving treatment or currently suffering from asthma symptoms were interviewed among nationals randomly surveyed from the most populated urban areas in Oman (Muscat, Sohar and Nizwa). The standard AIR questionnaire was used to assess symptom severity, health care utilisation, limitation of activity and medication use.
RESULTS: From 201 asthmatic participants, 21% were under 16 years and 43% were female. Tobacco use was low in our asthmatics. Disparity in asthma perception was wide in Oman; while 57% of asthmatics perceived their asthma as well or completely controlled, actually 54% had poorly or not well controlled asthma. All recommendations for asthma control by the Global Initiative for Asthma were largely unmet, especially in child asthmatics, with 44% reporting night awakenings due to asthma during the previous 4 weeks and 47% exercise-induced asthma in the previous 12 months. Overall, 32.6% of children and 34.8% of adults reported absence due to asthma from school/work during the previous year. Use of preventive inhaled corticosteroids was only 5.0%, one of the lowest even within the AIR Gulf and Near East study, producing an unacceptable ratio ICS/SABA (inhaled corticosteroid/short acting beta-agonist) of 0.054 in Omani asthmatics.
CONCLUSION: Asthma control in Oman falls far below the goals of current international guidelines therefore corrective strategies are needed.

Entities:  

Keywords:  Adult; Asthma; Asthma Prevention & Control; Child; Health survey; Oman

Year:  2011        PMID: 21509207      PMCID: PMC3074685     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  9 in total

1.  Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group.

Authors:  P Lagerløv; C C Veninga; M Muskova; E Hummers-Pradier; C Stålsby Lundborg; M Andrew; F M Haaijer-Ruskamp
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

2.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

Authors:  K F Rabe; P A Vermeire; J B Soriano; W C Maier
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

3.  Epidemiology Standardization Project (American Thoracic Society).

Authors:  B G Ferris
Journal:  Am Rev Respir Dis       Date:  1978-12

4.  Level control of asthma patients in chest specialist clinics.

Authors:  Nasser Al Busaidi; Suad Al Mukhaini
Journal:  Oman Med J       Date:  2009-07

5.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

Authors:  Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

6.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

7.  A relatively high prevalence and severity of asthma, allergic rhinitis and atopic eczema in schoolchildren in the Sultanate of Oman.

Authors:  Bazdawi M S Al-Riyami; Omar A S Al-Rawas; Asiya A Al-Riyami; Lyla G Jasim; Ali J Mohammed
Journal:  Respirology       Date:  2003-03       Impact factor: 6.424

8.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

9.  Asthma insights and reality in the Gulf and the near East.

Authors:  M Khadadah; B Mahboub; N H Al-Busaidi; N Sliman; J B Soriano; J Bahous
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 2.373

  9 in total
  6 in total

Review 1.  The Burden of Asthma in Oman.

Authors:  Nasser Al-Busaidi; Zulfikar Habibulla; Malvika Bhatnagar; Nabil Al-Lawati; Yaqoub Al-Mahrouqi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

2.  Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study.

Authors:  Ashraf Alzaabi; Nasser Al Busaidi; Rohit Pradhan; Fathelrahman Shandy; Naseem Ibrahim; Moulham Ashtar; Khaled Khudadah; Khaled Hegazy; Mohamed Samir; Mohamed Negm; Hisham Farouk; Arwa Al Khalidi; Maarten Beekman
Journal:  Asthma Res Pract       Date:  2022-07-07

3.  The asthma cost in oman.

Authors:  Nasser H Al-Busaidi; Zulfikar Habibullah; Joan B Soriano
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

4.  Asthma Clinics in Primary Healthcare Centres in Oman: Do they make a difference?

Authors:  Abdulaziz Al-Mahrezi; Sawsan Baddar; Sheikha Al-Siyabi; Safaa Al-Kindi; Ibrahim Al-Zakwani; Omar Al-Rawas
Journal:  Sultan Qaboos Univ Med J       Date:  2018-09-09

5.  Pulmonary Function Test Outcomes in Adult Omani Patients: Preliminary findings from a single-centre study.

Authors:  Anan Al Jabri; Ruqaiya Al Hinai; Ruth Balaji; Sharifa Al Harrasi; Deepali S Jaju; Hajar Al Rajaibi
Journal:  Sultan Qaboos Univ Med J       Date:  2022-08-25

6.  Assessing control of asthma in Jush, Jimma, South West Ethiopia.

Authors:  Kirubel Zemedkun; Kifle Woldemichael; Gobezie Tefera
Journal:  Ethiop J Health Sci       Date:  2014-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.